Active substanceFusidic acidFusidic acid
Dosage form: & nbspointment for external use
Composition:
In 1 g of ointment contains:
Active substance: sodium fusidate - 20 mg.
Excipients: lanolin-46 mg; cetyl alcohol-4 mg, paraffin liquid-140 mg, paraffin soft white-790 mg.

Description:
Homogeneous translucent ointment from yellowish to white

Pharmacotherapeutic group:antibiotic of polycyclic structure
ATX: & nbsp

D.09.A.A.02   Fusidic acid

Pharmacodynamics:
Bacteriostatic antibiotic.
Fusidic acid belongs to the group of fusidins, antimicrobial compounds, the mechanism of their action is associated with a violation of protein synthesis in the bacterial cell.
Gram-positive bacteria and Gram-negative cocci are sensitive to fusidic acid, for example, Staphylococcus aureus, Staphylococcus epidermidis (including methicillin-resistant nongams), Nocardia asteroids, Corynebacterium minutissimum, Streptococcus pyogenes, Pseudomonas spp, Clostridium spp., Neisseria meningitidis, Neisseria gonorrhoeae, Inactive against Escherichia coli, Salmonella spp., Proteus spp.and etc.' Gram-negative bacteria, as well as protozoa and fungi.

Pharmacokinetics:With external use, systemic absorption of fusidic acid is low. In the systemic blood stream does not fall.
Indications:
Skin infections; the bacteria, sensitive to fusidic acid.

Contraindications:
Hypersensitivity to the components of the drug.

Carefully:pregnancy, lactation
Dosing and Administration:
Outwardly.
In adults and children from birth to 18 years, ointment is applied to the affected areas of the skin with a thin layer 3-4 times a day.
When using gauze bandages, the frequency of application can be reduced to 1 to 2 times a day. *
The duration of treatment depends on the form and severity of the disease and on average is 7-14 days.

Side effects:
The incidence of side effects is very rare - side effects may be expected in about 5% of patients.
The following are data on adverse adverse reactions, depending on the
frequency of occurrence
Very often> 1/10
Often> 1/100 and <1/10
Infrequently> 1/1000 and <1/100
Rarely> 1/10000 and <1/1000 Very rarely <1/10000
Disturbances from the skin and subcutaneous tissues:
Infrequently:
Rash (erythematous, maculopapular, pustular), skin irritation, including pain, burning sensation, tingling sensation on the skin, itching, dry skin, contact dermatitis, Rarely:
urticaria, angioedema, eczema, periorbital edema, erythema. Immune system disorders:
Rarely:
Allergic reactions.
Disorders from the side of the organ of vision:
Rarely:

Irritation of the conjunctiva.
If any of the side effects listed in the manual are aggravated, or if you notice any other side effects not listed in the instructions, tell your doctor.

Overdose:
Overdose is unlikely.

Interaction:not identified
Special instructions:
Do not apply Fucidine® Ointment on the skin in the eye area, because sodium fusidate, when exposed to the eyes, causes irritation of the conjunctiva.
Fucidin® "ointment contains lanolin and cetyl alcohol, which can cause local allergic skin reactions (eg, contact dermatitis).
When using sodium fusidate, bacterial resistance may develop. As with other antibiotics, prolonged or recurring use may increase the risk of developing resistance to antibiotics.

Effect on the ability to drive transp. cf. and fur:
Influence on ability to drive vehicles and complex mechanisms is not revealed.

Form release / dosage:
Ointment for external use 2%.

Packaging:
15 g of the drug in an aluminum tube, lacquered from the inside with a screwed polyethylene lid.
1 tuba together with instructions for use in a cardboard box.

Storage conditions:
Store at a temperature not exceeding 30 ° C.
Keep out of the reach of children.

Shelf life:
3 years.
Do not use after expiry date.

Terms of leave from pharmacies:On prescription
Registration number:П N011114 / 02
Date of registration:31.05.2010
The owner of the registration certificate:Leo Pharmaceutical Products Co., Ltd. A / S (Leo Pharma A / S) Leo Pharmaceutical Products Co., Ltd. A / S (Leo Pharma A / S) Denmark
Manufacturer: & nbsp
Representation: & nbspLEO Pharmaceutical Products Ltd.LEO Pharmaceutical Products Ltd.
Information update date: & nbsp27.09.2015
Illustrated instructions
    Instructions
    Up